LA

Laveena Arora

Active Director Director DIN 09425108
DIN 09425108 First appointment Dec 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value •••• Premium profile

About Laveena Arora

Data last updated:

Laveena Arora is a Director at Sysmed Biotech Private Limited (since 2021). The company operates in Pharma. Sysmed Biotech Private Limited reported revenue of ₹1.93 Cr (FY 2025).

DIN 09425108
Primary Designation Director
Industry Pharma
First Appointment 06 Dec 2021
Oldest Company Age 4 yrs
Largest company Sysmed Biotech Private Limited · ₹1.93 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sysmed Biotech Private Limited U51909GJ2021PTC127755
Director06 Dec 20212021₹1.93 Cr (FY 2025)Active

Board colleagues of Laveena Arora

Directorship timeline

Open interactive timeline →
Sysmed Biotech Private Limited
Premium access

Shareholding and investment profile for Laveena Arora

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Laveena Arora

Laveena Arora currently holds 1 directorship: Sysmed Biotech Private Limited (Director, since 06 Dec 2021, revenue ₹1.93 Cr (FY 2025)).

Laveena Arora was first appointed on 06 Dec 2021 as Director at Sysmed Biotech Private Limited.

The current boards of Laveena Arora's companies include Kulvinder Kaur (Sysmed Biotech Private Limited), Mandeep Kaur Channa (Sysmed Biotech Private Limited), Neelam Lalit Kapoor (Sysmed Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available